If the newsletter is not displayed correctly, please visit our website:   >>>

Newsletter EPO GmbH: Tuesday, October 08, 2019

EORTC-NCI-AACR International Conference in Boston October 26 - 30, 2019

EPO will be present at the EORTC-NCI-AACR International Conference in Boston, USA

EPO at 31st EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics, October 26 - 30, 2019

At this conference, EPO will present its newest developments in cancer models for preclinical studies as part of the CRO services.

Our posters will cover the broad range of EPO's achievements in PDX development including molecular characterization of models, humanized mouse models and development of personalized models for clinical translation. The EPO experts (Dr. Jens Hoffmann and Dr. Michael Becker) will be happy to meet you at the posters and discuss our research accomplishments.

Presentation time at the Poster Session - Animal Models:

When: Sunday, October 27, 12:30 pm - 4:00 pm, Hall D, Hynes Convention Center 

  Poster #A006: Preclinical models from rare aggressive tumors: Establishment, drug sensitivity and genomic analyses of mesothelioma PDX as models for oncology drug development 
Poster #A013 Preclinical case study: Patient-derived head and neck cancer xenograft on mice humanized with autologous immune cells, a model for personalized immuno-oncology research
Poster #A014 Gastric cancer PDX models for predictive preclinical studies: Establishment, drug sensitivity, and genomic characterization


We hope to have the pleasure of seeing you at the AACR meeting and providing you with
any information you need!

If you are interested to know more about EPO’s expertise,
please visit us:


We are looking forward meeting you there.

      Connect with us: Jens.Hoffmann@epo-berlin.com to schedule a meeting with our experts.


EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH
Robert-Rössle-Straße 10, Haus 82
13125 Berlin Germany

Amtsgericht Charlottenburg,Sitz Berlin, HRB 61814

If you no longer wish to receive this newsletter, please click on unsubscribe. 

Copyright:EPO GmbH© 2019